Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
Ensysce Biosciences CEO, Dr. Lynn Kirkpatrick, presented at the inaugural Pain Therapeutics Summit Europe in Amsterdam on May 7-8, 2026. Her presentation, titled 'Chemical Control, Clinical Confidence: Rethinking Opioids,' outlined a new approach to opioid development that aims to improve safety and reduce misuse. Dr.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.